These trials completed more than 12 months ago and should have reported results.

These trials are not yet due to report results: some are ongoing, some completed within the past 12 months.

These trials have problematic data on the registry. Details why »

Status Trial ID Title Completion date Category
Listed as ongoing, but also has a completion date and reported results 2005-001074-27 A Multi-Centre, Double-Blind, Placebo-Controlled, Ascending-Dose, Clinical Trial of Intra-venous Microplasmin Administration in Patients with Acute Ischemic Stroke 2008-05-05 bad-data
Reported results 2005-001075-35 AN OPEN-LABEL CLINICAL TRIAL OF INTRA-ARTERIAL MICROPLASMIN ADMINISTRATION IN PATIENTS WITH ACUTE INTRACRANIAL VERTEBROBASILAR ARTERY OCCLUSION 2008-09-16 due-trials
Ongoing, reported early 2005-001171-36 A Dose-Escalation Clinical Trial of Intravitreal Microplasmin in Patients undergoing Surgical Vitrectomy for Vitreomacular Traction Maculopathy. not-yet-due
Listed as ongoing, but also has a completion date and reported results 2006-004626-93 A randomised, sham-injection controlled, double-masked, ascending dose, dose range-finding trial of microplasmin intravitreal injection for non-surgical PVD induction for treatment of diabetic macular... 2010-05-17 bad-data
Reported results 2006-005731-16 An Open Label Clinical Trial of Microplasmin Administered via the Trellis-8 Infusion System for the Treatment of Acute Iliofemoral Deep Vein Thrombosis 2008-09-12 due-trials
Completed, but no date, and reported results 2006-006085-42 A Randomized, Sham-Injection Controlled, Double-Masked, Ascending-Dose, Dose-Range-Finding, Multicenter Trial of Microplasmin Intravitreal Injection for Non-Surgical PVD Induction for Treatment of Vit... bad-data
Reported results 2008-004393-40 A randomized, placebo controlled, double-masked, multicenter trial of microplasmin intravitreal injection for non-surgical treatment of focal vitreomacular adhesion. 2010-06-15 due-trials
Reported results 2008-004539-39 Single Intravenous Administration of TB-402 for the Prophylaxis of Venous hromboembolic Events (VTE) After Total Knee Replacement Surgery: A Dose-Escalating, Multicenter, Randomised, Active-Controlled... 2010-01-22 due-trials
Listed as ongoing, but also has a completion date and reported results 2008-004844-35 A randomized, sham-injection controlled, double-masked, multicenter trial of microplasmin intravitreal injection for treatment of exudative age-related macular degeneration (AMD). 2012-12-06 bad-data
Completed, but no date, and reported results 2008-005228-10 An Open Label, Single Center Trial of Microplasmin Intravitreal Injection for Non-Surgical Treatment of Focal Vitreomacular Adhesion bad-data
Completed, but no date, and reported results 2010-018919-16 An Open-Label, Ascending- Exposure-Time, Single Center Trial to Evaluate the Pharmacokinetic Properties of Ocriplasmin (Generic Name of the Molecule Microplasmin) Intravitreal Injection in Subjects Sc... bad-data
Listed as ongoing, but also has a completion date and reported results 2010-023383-40 Single Intravenous Administration of TB-402 for the Prophylaxis of Venous Thromboembolic Events (VTE) After Total Hip Replacement Surgery: A Phase IIb, Multicentre, Randomised, Active-Controlled, Doub... 2012-03-07 bad-data
Ongoing 2015-002415-15 A PHASE 2, RANDOMISED, DOUBLE-MASKED, SHAM-CONTROLLED, MULTI-CENTRE STUDY TO EVALUATE THE EFFICACY AND SAFETY OF OCRIPLASMIN IN INDUCING TOTAL POSTERIOR VITREOUS DETACHMENT (PVD) IN SUBJECTS WITH NON-... not-yet-due
Completed, report not yet due 2016-002100-25 A Phase 2, single-masked, multicentre study to evaluate the safety and efficacy of 2 dose levels of THR-317 for the treatment of diabetic macular oedema (DME) 2018-04-11 not-yet-due
Ongoing 2017-003897-15 A Phase 2, randomised, single-masked, active-controlled, multicentre study to evaluate the efficacy and safety of intravitreal THR-317 administered in combination with ranibizumab, for the treatment o... not-yet-due